Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jiaming Zhou, Xiaoyan Guo, Pinzhu Huang, Shuyun Tan, Rongwan Lin, Huanmiao Zhan, Xiaofeng Wu, Tuoyang Li, Mingzhe Huang & Meijin Huang. (2022) HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up. Cancer Management and Research 14, pages 1581-1594.
Read now
Read now
Kevin Chih-Yang Huang, Shu-Fen Chiang, Tao-Wei Ke, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Hsin-Yu Chang, Ji-An Liang, William Tzu-Liang Chen & K. S. Clifford Chao. (2021) DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. OncoImmunology 10:1.
Read now
Read now
Luka de Vos, Ingela Grünwald, Emma Grace Bawden, Jörn Dietrich, Kathrin Scheckenbach, Constanze Wiek, Romina Zarbl, Friedrich Bootz, Jennifer Landsberg & Dimo Dietrich. (2020) The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas. Epigenetics 15:11, pages 1195-1212.
Read now
Read now
Yang-chun Feng, Wen-li Ji, Na Yue, Yan-chun Huang & Xiu-min Ma. (2018) The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance. Cancer Management and Research 10, pages 105-113.
Read now
Read now
Timo J. Vogt, Heidrun Gevensleben, Jörn Dietrich, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg, Diane Goltz & Dimo Dietrich. (2018) Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5′-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients. OncoImmunology 7:8.
Read now
Read now
Articles from other publishers (52)
Zhuo Chen, Meng-Wei Yao, Xiang Ao, Qing-Jia Gong, Yi Yang, Jin-Xia Liu, Qi-Zhou Lian, Xiang Xu & Ling-Jing Zuo. (2023) The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells. Chinese Journal of Traumatology.
Crossref
Crossref
Cristina Moreta-Moraleda, Cristina Queralt, Carla Vendrell-Ayats, Sonia Forcales & Eva Martínez-Balibrea. (2023) Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?. Pharmacological Research 196, pages 106924.
Crossref
Crossref
Xuwen Lin, Chenyu Zong, Zhihan Zhang, Weiyi Fang & Ping Xu. (2023) Progresses in biomarkers for cancer immunotherapy. MedComm 4:5.
Crossref
Crossref
Friederike Hoffmann, Alina Franzen, Luka de Vos, Lennert Wuest, Zsófi Kulcsár, Simon Fietz, Alexander Philippe Maas, Sarah Hollick, Marie Yatou Diop, Jennis Gabrielpillai, Timo Vogt, Pia Kuster, Romina Zarbl, Joern Dietrich, Glen Kristiansen, Peter Brossart, Jennifer Landsberg, Sebastian Strieth & Dimo Dietrich. (2023) CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma. Clinical Epigenetics 15:1.
Crossref
Crossref
Yingqi Xu, Jianlin Xu, Rong Qiao, Hua Zhong, Jinjing Xia & Runbo Zhong. (2023) Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression. Translational Oncology 33, pages 101671.
Crossref
Crossref
Goran Micevic, Marcus W. Bosenberg & Qin Yan. (2023) The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy. Clinical Cancer Research 29:7, pages 1173-1182.
Crossref
Crossref
Friederike Hoffmann, Anne Fröhlich, Judith Sirokay, Luka de Vos, Romina Zarbl, Jörn Dietrich, Sebastian Strieth, Jennifer Landsberg & Dimo Dietrich. (2023) DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma. Melanoma Research 33:2, pages 116-125.
Crossref
Crossref
Antoinette van Weverwijk & Karin E. de Visser. (2023) Mechanisms driving the immunoregulatory function of cancer cells. Nature Reviews Cancer 23:4, pages 193-215.
Crossref
Crossref
Trine V. Larsen, Nina Dybdal, Tina F. Daugaard, Johanne Lade-Keller, Lin Lin, Boe S. Sorensen & Anders L. Nielsen. (2023) Examination of the Functional Relationship between PD-L1 DNA Methylation and mRNA Expression in Non-Small-Cell Lung Cancer. Cancers 15:6, pages 1909.
Crossref
Crossref
Nivedita Sharma, Anjali Tomar & P. K. Tiwari. 2023. Gallbladder Cancer. Gallbladder Cancer
201
235
.
Zhuandi Liu, Xibao Yu, Ling Xu, Yangqiu Li & Chengwu Zeng. (2022) Current insight into the regulation of PD-L1 in cancer. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Dennis Niebel, Anne Fröhlich, Romina Zarbl, Simon Fietz, Luka de Vos, Timo J. Vogt, Jörn Dietrich, Judith Sirokay, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Sebastian Strieth, Jennifer Landsberg & Dimo Dietrich. (2022) DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy. Clinical Epigenetics 14:1.
Crossref
Crossref
Zerui Gao, Xingyi Ling, Chengyu Shi, Ying Wang & Aifu Lin. (2022) Tumor immune checkpoints and their associated inhibitors肿瘤免疫检查点及与其相关抑制剂. Journal of Zhejiang University-SCIENCE B 23:10, pages 823-843.
Crossref
Crossref
Minh Phuong Dong, Le Thi Thanh Thuy, Dinh Viet Hoang, Hoang Hai, Truong Huu Hoang, Misako Sato-Matsubara, Vu Ngoc Hieu, Atsuko Daikoku, Ngo Vinh Hanh, Hayato Urushima, Ninh Quoc Dat, Sawako Uchida-Kobayashi, Masaru Enomoto, Naoko Ohtani, Akihiro Tamori & Norifumi Kawada. (2022) Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response Patients. The American Journal of Pathology 192:10, pages 1379-1396.
Crossref
Crossref
Yunxia Ma, Rumyana Marinkova, Miljana Nenkov, Lai Jin, Otmar Huber, Jürgen Sonnemann, Natália Peca, Nikolaus Gaßler & Yuan Chen. (2022) Tumor-Intrinsic PD-L1 Exerts an Oncogenic Function through the Activation of the Wnt/β-Catenin Pathway in Human Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 23:19, pages 11031.
Crossref
Crossref
Luka de Vos, Tzaitel Maria Carrillo Cano, Romina Zarbl, Niklas Klümper, Damian Johannes Ralser, Alina Franzen, Emmanuelle Herr, Jennis Gabrielpillai, Timo Jakob Vogt, Jörn Dietrich, Sebastian Strieth, Jennifer Landsberg & Dimo Dietrich. (2022) CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma. Journal of Immunotherapy 45:7, pages 324-334.
Crossref
Crossref
Hemant Gujar, Arjun Mehta, Hong-Tao Li, Yvonne C. Tsai, Xiangning Qiu, Daniel J. Weisenberger, Miriam Galvonas Jasiulionis, Gino K. In & Gangning Liang. (2021) Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma. Genome Medicine 13:1.
Crossref
Crossref
Zhitao Li, Guoqiang Sun, Guangshun Sun, Ye Cheng, Liangliang Wu, Qian Wang, Chengyu Lv, Yichan Zhou, Yongxiang Xia & Weiwei Tang. (2021) Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges. Frontiers in Oncology 11.
Crossref
Crossref
Satu Mäki-Nevala, Sanjeevi Ukwattage, Erkki-Ville Wirta, Maarit Ahtiainen, Ari Ristimäki, Toni T. Seppälä, Anna Lepistö, Jukka-Pekka Mecklin & Päivi Peltomäki. (2021) Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis. Biomolecules 11:10, pages 1440.
Crossref
Crossref
Julie Sanceau & Angélique Gougelet. (2021) Epigenetic mechanisms of liver tumor resistance to immunotherapy. World Journal of Hepatology 13:9, pages 979-1002.
Crossref
Crossref
Hao Zhang, Ziyu Dai, Wantao Wu, Zeyu Wang, Nan Zhang, Liyang Zhang, Wen-Jing Zeng, Zhixiong Liu & Quan Cheng. (2021) Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Ioannis A. Vathiotis, Georgia Gomatou, Dimitrios J. Stravopodis & Nikolaos Syrigos. (2021) Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis. International Journal of Molecular Sciences 22:10, pages 5383.
Crossref
Crossref
S. Hua, M. Gu, Y. Wang, D. Ban & H. Ji. (2020) Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells. Clinical and Translational Oncology 23:4, pages 750-756.
Crossref
Crossref
Mohammad Amini, Maryam Hejazi, Khodayar Ghorban, Ahad Mokhtarzadeh & Behzad Baradaran. (2021) Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer. Gene 772, pages 145376.
Crossref
Crossref
Ming Yi, Mengke Niu, Linping Xu, Suxia Luo & Kongming Wu. (2021) Regulation of PD-L1 expression in the tumor microenvironment. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Jeong Yeon Kim, Jung Kyoon Choi & Hyunchul Jung. (2020) Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer. Clinical Epigenetics 12:1.
Crossref
Crossref
Zhou Jiaming, Huang Pinzhu, Guo Xiaoyan, Tan Shuyun, Lin Rongwan, Zhan Huanmiao, Wu Xiaofeng, Xiao Yuanlv, Huang Mingzhe, Yu Hongen, Huang Meijin & Wang Jianping. (2020) HBV infection may reduce the risk of metachronous liver metastasis in postoperative pathological stage 2 colorectal cancer. International Journal of Colorectal Disease 35:12, pages 2205-2217.
Crossref
Crossref
Katie Hudson, Neil Cross, Nicola Jordan-Mahy & Rebecca Leyland. (2020) The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment. Frontiers in Immunology 11.
Crossref
Crossref
Ling Wu, Weihao Lin, Qing Liao, Hui Wang, Chuang Lin, Lihua Tang, Weidong Lian, Zetao Chen, Kaitao Li, Lijun Xu, Rui Zhou, Yanqing Ding & Liang Zhao. (2020) Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation. Cell Reports 33:4, pages 108327.
Crossref
Crossref
Anne Fröhlich, Judith Sirokay, Simon Fietz, Timo J. Vogt, Jörn Dietrich, Romina Zarbl, Mike Florin, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Lukas Flatz, Sandra S. Ring, Carsten Golletz, Torsten Pietsch, Sebastian Strieth, Peter Brossart, Gerrit H. Gielen, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg & Dimo Dietrich. (2020) Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. eBioMedicine 59, pages 102962.
Crossref
Crossref
Comfort E. Ojedapo, Aliyu Muhammad, Grace S. N. Kia, Musa M. Abarshi, Maryam Abdulazeez, Joy Cecilia Atawodi & Jacob K. P. Kwaga. (2020) Rabies virus infection in mice up-regulates B7-H1 via epigenetic modifications. VirusDisease 31:3, pages 388-394.
Crossref
Crossref
Reem Saleh, Salman M. Toor, Varun Sasidharan Nair & Eyad Elkord. (2020) Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression. Frontiers in Immunology 11.
Crossref
Crossref
Niklas Klümper, Damian J Ralser, Emma Grace Bawden, Jenny Landsberg, Romina Zarbl, Glen Kristiansen, Marieta Toma, Manuel Ritter, Michael Hölzel, Jörg Ellinger & Dimo Dietrich. (2020)
LAG3
(
LAG-3
,
CD223
) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
. Journal for ImmunoTherapy of Cancer 8:1, pages e000552.
Crossref
Crossref
Yoko Yasuda, Kazuaki Tokunaga, Tomoaki Koga, Chiyomi Sakamoto, Ilya G. Goldberg, Noriko Saitoh & Mitsuyoshi Nakao. (2020) Computational analysis of morphological and molecular features in gastric cancer tissues. Cancer Medicine 9:6, pages 2223-2234.
Crossref
Crossref
Kevin Chih-Yang Huang, Shu-Fen Chiang, William Tzu-Liang Chen, Tsung-Wei Chen, Ching-Han Hu, Pei-Chen Yang, Tao-Wei Ke & K. S. Clifford Chao. (2020) Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer. Cancers 12:2, pages 462.
Crossref
Crossref
Anne Fröhlich, Sophia Loick, Emma Grace Bawden, Simon Fietz, Jörn Dietrich, Eric Diekmann, Gonzalo Saavedra, Holger Fröhlich, Dennis Niebel, Judith Sirokay, Romina Zarbl, Gerrit H. Gielen, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg & Dimo Dietrich. (2020) Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma. EBioMedicine 52, pages 102647.
Crossref
Crossref
Dan Lv, Chengjuan Xing, Lin Cao, Yuejian Zhuo, Tao Wu & Na Gao. (2019) PD‑L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer. Oncology Letters.
Crossref
Crossref
Huihua Cao, Qing Wang, Zhenyan Gao, Zhan Yu, Yugang Wu & Qicheng Lu. (2019) Programmed death-ligand 1 and survival in colorectal cancers: A meta-analysis. The International Journal of Biological Markers 34:4, pages 356-363.
Crossref
Crossref
Eva Leufven & Øystein Bruserud. (2019) Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments. Current Medicinal Chemistry 26:28, pages 5244-5261.
Crossref
Crossref
Verena Sailer, Ulrike Sailer, Emma Grace Bawden, Romina Zarbl, Constanze Wiek, Timo J. Vogt, Joern Dietrich, Sophia Loick, Ingela Grünwald, Marieta Toma, Carsten Golletz, Andreas Gerstner, Glen Kristiansen, Friedrich Bootz, Kathrin Scheckenbach, Jennifer Landsberg & Dimo Dietrich. (2019) DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature. EBioMedicine 48, pages 341-352.
Crossref
Crossref
Xiangfeng Shen, Lihong Zhang, Jicheng Li, Yulin Li, Yishu Wang & Zhi-Xiang Xu. (2019) Recent Findings in the Regulation of Programmed Death Ligand 1 Expression. Frontiers in Immunology 10.
Crossref
Crossref
Xue Li, Zhenni Wang, Jiansheng Huang, Huazao Luo, Sibo Zhu, Han Yi, Liuhai Zheng, Bo Hu, Lili Yu, Lingzhi Li, Jun Xie & Naishuo Zhu. (2019) Specific zinc finger‐induced methylation of PD‐L1 promoter inhibits its expression. FEBS Open Bio 9:6, pages 1063-1070.
Crossref
Crossref
Philipp Lingohr, Jonas Dohmen, Alexander Semaan, Vittorio Branchi, Jörn Dietrich, Friedrich Bootz, Jörg C Kalff, Hanno Matthaei & Dimo Dietrich. (2019)
Clinicopathological, immune and molecular correlates of
PD-L2
methylation in gastric adenocarcinomas
. Epigenomics 11:6, pages 639-653.
Crossref
Crossref
Goran Micevic, Durga Thakral, Meaghan McGeary & Marcus W. Bosenberg. (2018) PD‐L1 methylation regulates PD‐L1 expression and is associated with melanoma survival. Pigment Cell & Melanoma Research 32:3, pages 435-440.
Crossref
Crossref
Yan Li, Meizhi He, Yaoyao Zhou, Chen Yang, Shuyi Wei, Xiaohui Bian, Odong Christopher & Lang Xie. (2019) The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Ramón Cantero-Cid, José Casas-Martin, Enrique Hernández-Jiménez, Carolina Cubillos-Zapata, Aníbal Varela-Serrano, José Avendaño-Ortiz, Marta Casarrubios, Karla Montalbán-Hernández, Ignacio Villacañas-Gil, Laura Guerra-Pastrián, Begoña Peinado, Cristóbal Marcano, Luis A Aguirre & Eduardo López-Collazo. (2018) PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?. BMC Cancer 18:1.
Crossref
Crossref
Massimo Romani, Maria Pia Pistillo, Roberta Carosio, Anna Morabito & Barbara Banelli. (2018) Immune Checkpoints and Innovative Therapies in Glioblastoma. Frontiers in Oncology 8.
Crossref
Crossref
Alexander Semaan, Barbara Uhl, Vittorio Branchi, Philipp Lingohr, Friedrich Bootz, Glen Kristiansen, Jörg C. Kalff, Hanno Matthaei, Dimitrios Pantelis & Dimo Dietrich. (2018) Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis. Clinical Colorectal Cancer 17:2, pages e385-e393.
Crossref
Crossref
Yiting Wang, Huanbin Wang, Han Yao, Chushu Li, Jing-Yuan Fang & Jie Xu. (2018) Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion. Frontiers in Pharmacology 9.
Crossref
Crossref
Xiao-Yu Chen, Jing Zhang, Li-Dan Hou, Rui Zhang, Wei Chen, Hui-Ning Fan, Yan-Xia Huang, Hui Liu & Jin-Shui Zhu. (2018) Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma. International Journal of Immunopathology and Pharmacology 32, pages 205873841879031.
Crossref
Crossref
Federico Pio Fabrizio, Domenico Trombetta, Antonio Rossi, Angelo Sparaneo, Stefano Castellana & Lucia Anna Muscarella. (2018)
Gene code
CD274/PD-L1
: from molecular basis toward cancer immunotherapy
. Therapeutic Advances in Medical Oncology 10, pages 175883591881559.
Crossref
Crossref
Yingyi Zhang, Zhao Sun, Xinxin Mao, Huanwen Wu, Fei Luo, Xi Wu, Liangrui Zhou, Jing Qin, Lin Zhao & Chunmei Bai. (2017) Impact of mismatch-repair deficiency on the colorectal cancer immune microenvironment. Oncotarget 8:49, pages 85526-85536.
Crossref
Crossref